Clinical Trials Logo

Adenoviridae Infections clinical trials

View clinical trials related to Adenoviridae Infections.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05928962 Enrolling by invitation - Malignant Melanomas Clinical Trials

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

Start date: October 27, 2022
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is provide new treatment for patients with advanced melanoma who have failed previous immunotherapy. The main questions it aims to answer are: - Efficacy of PD1 monoclonal antibody combined with recombinant human adenovirus type 5 injection in patients with advanced malignant melanoma. - Safety of PD1 monoclonal antibody combined with recombinant human adenovirus type 5 injection in patients with advanced malignant melanoma.